Main menu

Tag: SeraCare

A PROJECT to improve the determination of levels of new HIV (human immunodeficiency virus) infections, a challenge that has presented a significant obstacle to the effective monitoring of the epidemic and the evaluation of interventions, has won a US$300,000 (UK£185,000) grant. SeraCare…

THE NEW HPV Genotype Qualification Panel from Seracare has been launched in response to rising demand for HPV (human papillomavirus) assay qualification. “Increased awareness of the risks of human papillomavirus (HPV) has generated a need for accurate testing,” said Chris…

SeraCare Life Sciences has expanded its range of mononuclear cells with the launch of off-the-shelf AccuCell human cord blood mononuclear cells (CBMNCs). Viability of these cells after thawing is validated at better than 90%, says SeraCare, making these cryopreserved CBMNCs…

THE LATEST offering in SeraCare Life Sciences’s range, SeraCon Vitamin D Depleted Diluent is a human plasma-based matrix for the development of vitamin D assays. The product is derived entirely from human plasma, with no equine or synthetic plasma, which…

SERACARE Life Sciences has launched five new infectious disease panels, including the first for parvovirus B19 which is associated with fifth disease. The other new products include panels for human immunodeficiency virus (HIV), hepatitus A (HAV), hepatitus B (HBV), and cytomegalovirus…

A NEW range of controls designed for the highly sensitive nucleic acid assays used in the detection of chlamydia and gonorrhea is now available from SeraCare. Accurun 341 controls are designed to monitor and validate the performance of molecular diagnostic…